Navigation Links
Access Pharmaceuticals Receives Final Marketing Approval From SFDA of China for MuGard
Date:2/24/2012

DALLAS and NEW YORK, Feb. 24, 2012 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that its MuGard partner in China, Rhei Pharmaceuticals HK Ltd., received regulatory and marketing approval for MuGard in China from the State Food and Drug Administration, or SFDA, to treat oral mucositis in cancer patients.  Manufacturing of MuGard will commence shortly in the United States to meet the demand created by Jian An, Rhei's sales and marketing partner in China.

Last year, Access and RHEI signed a $30 million supply agreement for MuGard to ensure manufacturing capacity of up to a minimum of $30 million of product in the licensed territories.  In addition, Access also approved a sub-license agreement between RHEI Pharmaceuticals and Jian An Pharmaceuticals ("Jian An") Limited in Shenzhen, China to leverage Jian An's extensive sales, marketing and regulatory infrastructure for the launch of MuGard in China and Taiwan. Jian An is headquartered in Shenzhen, China and has a 25-year history of selling pharmaceutical and other medical products in the China market.  Jian An has 1400 sales representatives covering all majors centers in China through 169 sales offices. 

Expressing enthusiasm on the approval, Jeffrey B. Davis, President and Chief Executive Officer of Access Pharmaceuticals, Inc. stated, "Receiving final marketing approval from the SFDA of China is a transformative milestone for our global MuGard program.  China represents a key target market with its large and increasingly affluent population and its desire for improved oncology care.  With the approval process now complete, we look forward to moving as quickly as we can to complete manufacturing so Rhei a
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
2. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
3. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
4. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
5. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
8. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
9. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
10. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
11. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)...  Cancer Treatment Institute of Colombia ... treatment: a carefully formulated, first-of-its-kind combination of salinomycin ... at treating multiple types of cancer. The team ... optimistic that it could significantly improve outcomes for ... "These two drugs are exceptional on ...
(Date:9/29/2014)... 2014 Apexus, LLC, the prime vendor ... that it has been selected by the Health ... in its role as the prime vendor through ... position for the past 10 years, will continue ... locations, drug manufacturers, pharmacy wholesalers, and other stakeholders ...
(Date:9/29/2014)... , Sept. 29, 2014  Guerbet, a ... medical imaging, has received a Drug Shortage Assistance ... for its assistance in preventing or alleviating a ... for its efforts related to the shortage of ... drug application, submitting several post-approval supplements to restart ...
Breaking Medicine Technology:Cancer Treatment Institute of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination of 3-Bromopyruvate and Salinomycin for Treatment of Multiple Types of Cancer 2Cancer Treatment Institute of Colombia Demonstrates Unprecedented Results Using Unique Cancer Drug Combination of 3-Bromopyruvate and Salinomycin for Treatment of Multiple Types of Cancer 3Apexus Wins HRSA Contract to Remain Prime Vendor of 340B Program 2Guerbet Receives FDA's Drug Shortage Assistance Award: Recognized for contributions to address a shortage of Ethiodol (ethiodized oil) injection 2
... honor of National Women,s Health Week, Someone With ... home health and medical supply online storefront, www.someonewith.com , ... catalog solutions for more than 2.5 million breast cancer survivors ... women who will be diagnosed with breast cancer this year. ...
... (NYSE Amex: ANX ) today reported financial results ... "We are pleased to have completed the acquisition of SynthRx ... to reach agreement on the protocol for a pivotal phase ... crisis," said Brian M. Culley, Chief Executive Officer of ADVENTRX. ...
Cached Medicine Technology:Someone With Opens its Doors to Create Online Marketplace for Breast Cancer Products and Services 2Someone With Opens its Doors to Create Online Marketplace for Breast Cancer Products and Services 3Someone With Opens its Doors to Create Online Marketplace for Breast Cancer Products and Services 4ADVENTRX Reports First Quarter 2011 Financial Results 2ADVENTRX Reports First Quarter 2011 Financial Results 3ADVENTRX Reports First Quarter 2011 Financial Results 4ADVENTRX Reports First Quarter 2011 Financial Results 5
(Date:9/30/2014)... In honor of National Breast Cancer Awareness ... courageous battles, Incredible Veins, Body & Skin is offering ... Cynosure. , “For cancer patients who receive radiation ... on their skin to accurately aim the radiation on ... survivors, they decide to have their tattoo removed as ...
(Date:9/30/2014)... Every New Year begins with a Resolution that will soon ... of effort, however most are out of mind in 30. Why? ... Instead of "spend more time with children", try something easy to ... Without a reminder, daily life gets in the way and efforts ... 3. Goals out of sight equals goals out of mind. ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 From October ... be exhibiting at the 2014 SHSMD Connections Annual Conference ... for Healthcare Strategy & Market Development (SHSMD) is proud ... marketing, public relations and communications, and strategic planning professionals ... About SHSMD Connections , The conference is a ...
(Date:9/30/2014)... Albany, IN (PRWEB) September 30, 2014 ... Dr. Ron Receveur encourages all persons who have received ... disease in a recent blog post. , The post, ... those with dental implants that if they don’t brush ... the same way people lose their natural teeth: the ...
(Date:9/30/2014)... Chicago, IL (PRWEB) September 30, 2014 ... cannabinoid clash,” opened Bryan W. Brickner, “and it’s ... Sleep Political Cannabinoid Science , new on the ... sleep research from the National Institutes of Health ... articles regarding: de-homeostatic sleep disturbances, REM transitions, aging ...
Breaking Medicine News(10 mins):Health News:Incredible Veins, Body & Skin Takes A Stand Against Breast Cancer With PicoSure® By Cynosure 2Health News:MMS, Inc. (Medical Marketing Service) to Attend the 2014 SHSMD Connections Annual Conference in October 2Health News:All on Four Dental Implants Dentist Writes Blog on Preventing Gum Disease 2Health News:All on Four Dental Implants Dentist Writes Blog on Preventing Gum Disease 3Health News:Homeostasis: Publius’ Sleep Political Cannabinoid Science ~ New on the Bryan William Brickner Blog 2
... at Children,s National Medical Center and the ... the results of the first successful application of "multiple ... muscular dystrophy in an animal larger than a ... "DNA band-aids" to skip over the parts of the ...
... SAN DIEGO, March 16 Gen-Probe Incorporated (Nasdaq: ... (AIM: TED) approved the acquisition of Tepnel by Gen-Probe by ... London earlier today.More than 99% of Tepnel shareholders voted in ... 30, 2009 and is structured as a "scheme of arrangement" ...
... Office Building Project Provides State-of-the-Art Healthcare for Rural ... Roads Ventures (HRV), a community development investment firm, ... program to provide equity and debt financing for ... rural communities in Virginia providing successful solutions to ...
... products contain allergens no matter what ingredients are listed, study ... number of food products with a "may contain" label actually ... of foods products without such a claim also contain allergens, ... came from smaller companies, noted the authors of a study ...
... March 16 /PRNewswire-Asia-FirstCall/ -- China Yongxin Pharmaceuticals, Inc. ... Board: CYXN), a leading manufacturer, distributor and retailer ... it has rolled out its Electronic Diagnosis System ... Changchun, Jilin. In order to ensure safety of ...
... adventure series results from a life of creative ... Ohio, March 16 Randy Patterson has spent ... a deadly, aggressive and extremely rare cancer called ... nine grueling spinal taps, mounting financial debt, and ...
Cached Medicine News:Health News:First treatment for muscular dystrophy in sight: Scientists successfully harness exon-skipping 2Health News:First treatment for muscular dystrophy in sight: Scientists successfully harness exon-skipping 3Health News:Tepnel Shareholders Approve Acquisition by Gen-Probe 2Health News:Tepnel Shareholders Approve Acquisition by Gen-Probe 3Health News:Tepnel Shareholders Approve Acquisition by Gen-Probe 4Health News:Hampton Roads Ventures Tackles U.S. Healthcare Crisis Community by Community 2Health News:Food Allergy Labeling Not Always Accurate 2Health News:Food Allergy Labeling Not Always Accurate 3Health News:China Yongxin Pharmaceuticals Inc. Launches Electronic Diagnosis System in its Changchun Drugstores 2Health News:China Yongxin Pharmaceuticals Inc. Launches Electronic Diagnosis System in its Changchun Drugstores 3Health News:Trinadgey Launches to Sci-Fi Lovers via New Online Portal Trinadgey.com 2
... The patented ratchet design provides fingertip ratchet ... Series I Instrument program offers state-of-the-art quality ... while maintaining strength and durability. Low profile ... tight joint spaces. Series I instruments are ...
... procedurally specific tip configurations provide maximum ... to all areas of the meniscus ... Graspers feature an infinite position sliding-lock ... tearing or slipping even in ...
Smith & Nephew ACUFEX scissors are constructed without pins for maximum strength, dependability, durability, and safety.,A wide range of tips and angles enable the surgeon to effectively dissect any ...
The most traditional style of instrument, a classical punch shape with the parrot beak upper jaw to aid in the capture of tissue....
Medicine Products: